Ladenburg Thalmann Financial Services’s Cumberland Pharmaceuticals CPIX Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio CPIX Stock Details CPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-136	Closed	-$1K	–	5294
2019 Q2	$1K	Buy	+136	New	+$825	﹤0.01%	5083
2019 Q1	–	Sell	-237	Closed	-$1K	–	5217
2018 Q4	$1K	Buy	+237	New	+$1.42K	﹤0.01%	5014
2016 Q2	–	Sell	-12	Closed	–	–	4750
2016 Q1	$0	Hold	12	–	–	﹤0.01%	4696
2015 Q4	$0	Hold	12	–	–	﹤0.01%	4682
2015 Q3	$0	Hold	12	–	–	﹤0.01%	4614
2015 Q2	$0	Hold	12	–	–	﹤0.01%	4660
2015 Q1	$0	Hold	12	–	–	﹤0.01%	4581
2014 Q4	$0	Buy	+12	New	+$62	﹤0.01%	4358
2013 Q3	–	Sell	-200	Closed	-$1K	–	3716
2013 Q2	$1K	Buy	+200	New	+$995	﹤0.01%	3449

Other funds holding CPIX

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

DGHMC

Dalton, Greiner, Hartman, Maher & Co New York $126M AUM 92.88% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Ladenburg Thalmann Financial Services's CPIX Position: Q3 2019 in Review

Ladenburg Thalmann Financial Services sold out of Cumberland Pharmaceuticals (CPIX) in Q3 2019, closing a stake of 136 shares — an estimated $1K sold.

Ladenburg Thalmann Financial Services first reported a position in CPIX in Q2 2013 and held it in 9 quarters. The position peaked at $1K in Q2 2019. 28 funds tracked by Wall St. Rank hold CPIX as of Q3 2019.

Ladenburg Thalmann Financial Services reported no remaining Cumberland Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
Ladenburg Thalmann Financial Services sold 136 Cumberland Pharmaceuticals shares in Q3 2019, an estimated $1K.
Ladenburg Thalmann Financial Services first reported a position in Cumberland Pharmaceuticals in Q2 2013 and held it in 9 quarters.
Ladenburg Thalmann Financial Services's Cumberland Pharmaceuticals position peaked at $1K in Q2 2019.
28 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q3 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q3 2019, filed 14 Nov 2019.